Zymeworks Inc.

Zymeworks Inc.verified

ZYME

Price:

$26.52

Market Cap:

$1.99B

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers S...[Read more]

Industry

Biotechnology

IPO Date

2017-04-28

Stock Exchange

NASDAQ

Ticker

ZYME

The Enterprise Value as of December 2025 (TTM) for Zymeworks Inc. (ZYME) is -43935349065.00

According to Zymeworks Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -43935349065.00. This represents a change of 319.73% compared to the average of -10467408710.89 of the last 4 quarters.

Zymeworks Inc. (ZYME) Historical Enterprise Value (quarterly & annually)

How has ZYME Enterprise Value performed in the past?

The mean historical Enterprise Value of Zymeworks Inc. over the last ten years is 722.40M. The current -43935349065.00 Enterprise Value has changed -608284.21% with respect to the historical average. Over the past ten years (40 quarters), ZYME's Enterprise Value was at its highest in in the December 2020 quarter at 2.18B. The Enterprise Value was at its lowest in in the September 2025 quarter at -44635882560.00.

Quarterly (TTM)
Annual

Average

722.40M

Median

484.21M

Minimum

125.46M

Maximum

2.15B

Zymeworks Inc. (ZYME) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zymeworks Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 318.71%

Maximum Annual Enterprise Value = 2.15B

Minimum Annual Increase = -79.61%

Minimum Annual Enterprise Value = 125.46M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.06B81.78%
2023584.65M318.71%
2022139.63M-79.61%
2021684.90M-68.11%
20202.15B33.83%
20191.60B318.16%
2018383.76M205.87%
2017125.46M-48.59%
2016244.04M-0.94%
2015246.35M16.74%

Zymeworks Inc. (ZYME) Average Enterprise Value

How has ZYME Enterprise Value performed in the past?

The current Enterprise Value of Zymeworks Inc. (ZYME) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

595.69M

5-year avg

923.93M

10-year avg

722.40M

Zymeworks Inc. (ZYME) Enterprise Value vs. Peers

How is ZYME’s Enterprise Value compared to its peers?

Zymeworks Inc.’s Enterprise Value is less than Maze Therapeutics, Inc. (1.76B), less than Ardelyx, Inc. (1.58B), less than Spyre Therapeutics, Inc. (1.96B), less than Pharvaris N.V. (1.34B), less than Intellia Therapeutics, Inc. (925.20M), less than BioCryst Pharmaceuticals, Inc. (2.30B), less than Immunome, Inc. (1.70B), less than Trevi Therapeutics, Inc. (1.67B), less than Wave Life Sciences Ltd. (1.07B), less than Upstream Bio, Inc. (1.46B),

Build a custom stock screener for Zymeworks Inc. (ZYME) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zymeworks Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zymeworks Inc. (ZYME) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zymeworks Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Zymeworks Inc.'s Enterprise Value?

What is the highest Enterprise Value for Zymeworks Inc. (ZYME)?

What is the 3-year average Enterprise Value for Zymeworks Inc. (ZYME)?

What is the 5-year average Enterprise Value for Zymeworks Inc. (ZYME)?

How does the current Enterprise Value for Zymeworks Inc. (ZYME) compare to its historical average?